68.00
+1.00
+(1.49%)
At close: 9:06:55 AM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
57,111.00
79,415.00
107,612.00
Investing Cash Flow
-283,663.00
-255,678.00
-28,287.00
Financing Cash Flow
196,023.00
196,813.00
-56,926.00
End Cash Position
62,118.00
61,924.00
41,374.00
Capital Expenditure
-284,120.00
-255,654.00
-27,732.00
Issuance of Capital Stock
--
36,000.00
--
Issuance of Debt
--
176,879.00
40,000.00
Free Cash Flow
-227,009.00
-176,239.00
79,880.00
12/31/2022 - 12/12/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
7814.TWO HORIEN
33.00
-4.76%
1295.TWO Synbio Tech Inc.
74.30
-0.27%
7790.TWO SSLab
72.00
+0.28%
7808.TWO BIONET TX Corp
46.00
-1.08%
7773.TWO FullHope
42.50
-1.62%
6986.TWO HeXun Biosciences Co., Ltd.
71.80
+1.84%
4170.TWO VBI
14.10
+0.71%
7427.TWO Great Novel Therapeutics Biotech & Medicals
31.75
+0.47%
7776.TWO Anya
37.90
+5.72%
6610.TWO TWi Biotechnology, Inc.
13.75
+0.73%